Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories

Dr Reddys Laboratories

BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 12, 16:00
2905.50
18.15 (0.63%)
VOLUME 6,559
LIVE
NSE
Dec 12, 15:55
2905.65
17.85 (0.62%)
VOLUME 403,810
News on Dr Reddys Laboratories
Select Year: 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Dr Reddy's Betapharm gets 8 drug contracts in Germany

9.02 am | 11 Dec 2008 |  Source: Business Line

Dr Reddys Laboratories on Wednesday announced that Betapharm AG, its wholly-owned subsidiary, has been tentatively offered eight products in differen...

Hold Dr Reddys Lab: Mukadam 

11.55 am | 04 Dec 2008 |  Source: CNBC-TV18

Shahina Mukadam, Director of Varun Capital Markets is of the view that one can continue to hold Dr Reddys Laboratories....

DRL bags order for seven products from Germany's AOK

3.25 pm | 03 Dec 2008 |  Source: CNBC-TV18

DRL has bagged an order to supply seven products to Germany's AOK. Four of these seven products are exclusive to DRL. The company will be able to supp...

Dr Reddys Laboratories can test Rs 455-465: Dutta 

12.01 pm | 25 Nov 2008 |  Source: CNBC-TV18

Devangshu Dutta, Consulting Editor of Outlook is of the view that Dr Reddys Laboratories can test Rs 455-465. If you are looking at a short term trade...

Hold Dr Reddys Laboratories: Baliga 

11.57 am | 25 Nov 2008 |  Source: CNBC-TV18

Ambareesh Baliga of Karvy Stock Broking is of the opinion that one can hold Dr Reddys Laboratories at this level but closer to Rs 470 or Rs 480 one sh...

Indian IT cos will continue to grow business: Gates

8.37 am | 06 Nov 2008 |  Source: Business Line

Lauding Indian IT industry for building an incredible reputation, the Microsoft Founder and the second richest man in the world, Mr Bill Gates, said...

Dr Reddy's to focus on eco-friendly manufacturing process

8.40 am | 05 Nov 2008 |  Source: Business Line

Pharma major Dr Reddys Laboratories Ltd will focus on green chemistry to make the process of drug design and manufacture more environmental friendl...

Sell Dr Reddys Labs below Rs 403: ICICIdirect.com

10.00 am | 04 Nov 2008 |  Source: Moneycontrol.com

ICICIdirect.com has recommended to sell Dr Reddys Laboratories below Rs 403 with a stoploss of Rs 404 and targets of Rs 399/370/lower....

Dr Reddys in race for $3.5-b German tender

9.30 am | 30 Oct 2008 |  Source: Business Line

Dr Reddys Laboratories Ltd is pinning hopes on winning an over-$3.5-billion sick fund tender in Germany next month to increase its revenue and pr...

Buy Dr Reddys Labs, target of Rs 581: Angel

1.52 pm | 25 Oct 2008 |  Source: Moneycontrol.com

Angel Broking has maintained its buy rating on Dr Reddys Laboratories (DRL) with a target of Rs 581. For 2QFY2009, DRL registered 26.2% yoy growth in ...

Revenue guidance of 25% for FY09: Dr Reddy Lab

7.11 pm | 23 Oct 2008 |  Source: Moneycontrol.com

Dr Reddy's Laboratories' Q2 FY09 consolidated net profit stood at Rs 86.6 crore as compared to Rs 110.5 crore. The numbers are based on Indian GAAP ac...

India growth muted due to competition, launch delays: DRL 

6.23 pm | 23 Oct 2008 |  Source: CNBC-TV18

GV Prasad of Dr Reddy's Laboratories, said Indian growth has been muted as new product launches did not go as scheduled. There was some infiltration ...

Dr Reddys Labs Q2 net profit at Rs 121 cr 

5.07 pm | 23 Oct 2008 |  Source: CNBC-TV18

Dr Reddys Laboratories has declared its second quarter results. The company's net sales were up 29.7 % at Rs 1615.1 crore versus Rs 1245.10 crore. Its...

Dr Reddys Labs Q2 net profit at Rs 121 cr

2.05 pm | 23 Oct 2008 |  Source: CNBC-TV18

Dr Reddys Laboratories has declared its second quarter results. The company's net sales were up 29.7 % at Rs 1615.1 crore versus Rs 1245.10 crore. Its...

Dr Reddys Q2 PAT seen down 50% at Rs 132 cr

7.00 pm | 22 Oct 2008 |  Source: CNBC-TV18

Dr Reddys Laboratories is to announce its second quarter results. According to CNBC-TV18 estiamtes, the companys Q2FY09 US GAAP net sales are seen up...

Buy Dr Reddys Labs, target of Rs 610: Karvy

12.10 pm | 17 Oct 2008 |  Source: Moneycontrol.com

Karvy Stock Broking has maintained its buy rating on Dr Reddys Laboratories with a target of Rs 610. Net revenues for the quarter are expected to grow...

DRL Sept '08 qtr PAT seen at Rs 160.4 Cr: Religare

6.00 pm | 08 Oct 2008 |  Source: Moneycontrol.com

Religare Hichens Harrison Research has come out with its earning estimates on Pharma sector for the quarter ended September 2008. According to the res...

Buy Dr Reddys Labs, target of Rs 650: J.P.Morgan

3.01 pm | 03 Oct 2008 |  Source: CNBC-TV18

J.P.Morgan has maintained its buy rating on Dr Reddys Laboratories with a target price of Rs 650, reports CNBC-TV18....

Dr Reddys launches subsidiary in US

8.50 am | 19 Sep 2008 |  Source: Business Line

Pharma major Dr Reddys Laboratories Ltd has launched Promius Pharma LLC, a wholly-owned subsidiary, for specialty business in Bridgewater, US....

Bulk drug production should be scaled up: Dr Reddys

8.49 am | 17 Sep 2008 |  Source: Business Line

Manufacturers of bulk drugs should invest in scaling-up their product diversity and quality, said Mr G.V. Prasad, Vice-Chairman and Chief Executive Of...

1 2 3 4
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.